Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jan 25, 2011

Premium

Innopsys has appointed Reuben Dharmaraj as US sales director for its high-resolution microarray scanners product line. Dharmaraj joins Carbonne, France-based Innopsys from life science consulting firm Ab Initio Pharmacodynamics. He has also held sales, marketing, and support positions at PerkinElmer, Aurora Biosciences, and Unisyn Technologies. He is also a founding principal at ChloroFill, a green structural material firm.

Dharmaraj holds an MSc in molecular glycobiology from the University of Tulsa and a BSc in the biosciences from Oral Roberts University. He will be based out of Innopsys' new US office in Chicago (BAN 11/4/2010).


Roche's Erich Hunziker plans to retire as chief financial officer, chief information officer, and deputy head of the corporate executive committee at the end of March. The firm's board of directors has appointed Alan Hippe to take over Hunziker's position as CFO. He will also be on Roche's corporate executive committee. He had been CFO at ThysenKrupp.


WaferGen Biosystems has appointed Arul Chinnaiyan to serve on its scientific advisory board. Chinnaiyan is currently director of the Michigan Center for Translational Pathology, and an investigator at the Howard Hughes Medical Institute.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more